Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

229.51 -6.77 (-2.87%)

Official Closing Price Updated: 7:00 PM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

90 91 Next >

4 Sectors That Thrive When Inflation Runs Hot

February 28, 2025

Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value

Via MarketBeat

Topics Economy World Trade

3 Reasons ABBV is Risky and 1 Stock to Buy Instead

February 28, 2025

AbbVie trades at $205.51 per share and has stayed right on track with the overall market, gaining 5.2% over the last six months. At the same time, the S&P 500 has returned 5.1%.

Via StockStory

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

February 27, 2025

Via The Motley Fool

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years ↗

February 24, 2025

Via Benzinga

How Is The Market Feeling About AbbVie? ↗

February 17, 2025

Via Benzinga

Is AbbVie Stock a Buy Now? ↗

February 15, 2025

Via The Motley Fool

2 High-Yield Dividend ETFs to Buy to Generate Passive Income ↗

February 23, 2025

With yields ranging between 3.6% and 7.3%, these dividend ETFs are great bets for generating passive income.

Via The Motley Fool

Topics ETFs

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

February 22, 2025

Gilead Pharmaceuticals is back to highs not seen in a decade as its HIV treatment franchise surges and awaits its 100% effective HIV prevention drug in summer

Via MarketBeat

Topics Death

Large Cap Biopharmaceutical Metrics And Performance Q1 2025 ↗

February 20, 2025

Tariffs could have big impact on earnings in 2025.

Via Talk Markets

Topics Stocks / Equities

2 Magnificent Dividend Growth Stocks to Load Up On Right Now ↗

February 20, 2025

Via The Motley Fool

4 Stocks and 1 Exchange-Traded Fund (ETF) I Can't Stop Buying ↗

February 19, 2025

Five great investments for any portfolio.

Via The Motley Fool

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

February 18, 2025

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting results tomorrow afternoon. Here’s what you need to know.

Via StockStory

Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich ↗

February 18, 2025

Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion.

Via Benzinga

Topics Government

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday? ↗

February 12, 2025

AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for prostate, gastric, and lung cancers.

Via Benzinga

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

February 12, 2025

From Xilio Therapeutics, Inc.; AbbVie Inc.

Via GlobeNewswire

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

February 11, 2025

Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

Healthcare And Biotech Playbook As Disruption Gathers Force ↗

February 10, 2025

The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.

Via Talk Markets

Topics ETFs Stocks / Equities

These Stocks Missed on Earnings, But Will Rebound Next Quarter

February 10, 2025

Here are three stocks from companies that missed on earnings but have strong support from analysts that makes each stock a solid Buy for the next year

Via MarketBeat

Gilead Sciences (GILD) Q4 Earnings: What To Expect

February 10, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Via StockStory

3 Fabulous Dividend Stocks to Buy in February ↗

February 09, 2025

Via The Motley Fool

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

February 09, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Via StockStory

Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow

February 09, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Via StockStory

3 Dividend Stocks to Double Up on Right Now ↗

February 09, 2025

Via The Motley Fool

These 2 Dividend Stocks Are Absolute Bargains Right Now ↗

February 08, 2025

Via The Motley Fool

3 Top AI-Powered Biotech Stocks to Buy in February ↗

February 06, 2025

Via The Motley Fool

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase ↗

February 05, 2025

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

February 03, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Via Chartmill

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

Top S&P500 movers in Monday's session ↗

February 03, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions